Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The landscape of rare genetic variants in familial Waldenström macroglobulinemia. Local targets link to admitted publications; unresolved targets remain external evidence.
Plasma cell disorders
10.1016/j.pop.2016.07.002 · 2016 · External reference
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database
10.1182/blood-2014-05-574871 · 2014 · External reference
Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database
10.1111/bjh.13264 · 2015 · External reference
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005
10.3109/10428194.2012.656103 · 2012 · External reference
Lymphoplasmacytic lymphoma
2017 · External reference
The epidemiology of Waldenström macroglobulinemia
10.1053/j.seminhematol.2023.03.008 · 2023 · External reference
Waldenstrom macroglobulinemia: tailoring therapy for the individual
10.1200/jco.22.00495 · 2022 · External reference
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
10.1053/sonc.2003.50038 · 2003 · External reference
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
10.1182/blood-2014-03-565135 · 2014 · External reference
Characterization of familial Waldenstrom's macroglobulinemia
10.1093/annonc/mdj111 · 2006 · External reference
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
10.3324/haematol.2009.008979 · 2009 · External reference
Familial Waldenström macroglobulinemia: families informing populations
10.1016/j.hoc.2018.05.006 · 2018 · External reference
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
10.1093/jncimonographs/lgu002 · 2014 · External reference
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden
10.1182/blood-2008-06-162768 · 2008 · External reference
Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families
10.1086/507687 · 2006 · External reference
Common genetic variants in candidate genes and risk of familial lymphoid malignancies
10.1111/j.1365-2141.2009.07790.x · 2009 · External reference
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
10.1038/s41467-018-06541-2 · 2018 · External reference
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
10.1182/blood-2015-11-680199 · 2016 · External reference
Screening and identification of a novel FHL2 mutation by whole exome sequencing in twins with familial Waldenström macroglobulinemia
10.1002/cncr.33454 · 2021 · External reference
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
10.1056/nejmoa1200710 · 2012 · External reference
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
10.1182/blood-2013-09-525808 · 2014 · External reference
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia
10.1182/blood-2014-01-550905 · 2014 · External reference
Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation
10.1182/blood-2009-10-247973 · 2010 · External reference
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
10.1016/s0197-2456(00)00098-2 · 2000 · External reference
Identification of genetic risk factors for familial urinary bladder cancer: an exome sequencing study
2021 · External reference
Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts
10.1038/s41588-020-0621-6 · 2020 · External reference
SAIGE-GENE+ improves the efficiency and accuracy of set-based rare variant association tests
10.1038/s41588-022-01178-w · 2022 · External reference
Cancer genome landscapes
10.1126/science.1235122 · 2013 · External reference
Realizing the promise of cancer predisposition genes
10.1038/nature12981 · 2014 · External reference
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
10.1002/ajmg.a.36887 · 2015 · External reference
SAMHD1 and the innate immune response to cytosolic DNA during DNA replication
10.1016/j.coi.2018.09.017 · 2019 · External reference
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus
10.1038/ng1845 · 2006 · External reference
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis
10.1111/j.1469-8749.2010.03727.x · 2010 · External reference
Clinical and molecular phenotype of Aicardi-Goutieres syndrome
10.1086/521373 · 2007 · External reference
Aicardi-Goutières syndrome
1993 · External reference
The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease
10.1074/jbc.m806155200 · 2008 · External reference
The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity
10.1074/jbc.m111.297903 · 2011 · External reference
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia
10.1182/blood-2016-01-695692 · 2016 · External reference
Cancer incidence and surveillance strategies in individuals with RASopathies
10.1002/ajmg.c.32018 · 2022 · External reference
The genomic landscape of hypodiploid acute lymphoblastic leukemia
10.1038/ng.2532 · 2013 · External reference
Age-related clonal hematopoiesis associated with adverse outcomes
10.1056/nejmoa1408617 · 2014 · External reference
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia
10.1111/bjh.15560 · 2019 · External reference
Extracolonic manifestations of lynch syndrome
10.1055/s-0032-1313781 · 2012 · External reference
Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?
10.1007/s00439-008-0542-4 · 2008 · External reference
